Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections worldwide and causes anal cancer. The incidence of HPV infections in renal transplant recipients is 17% to 45%. Using immunosuppression treatment has been associated with significantly lower risks of de novo malignancies and viral infections after kidney transplantation. We reported the results of switching Tacrolimus to Sirolimus in a kidney transplant recipient who suffered from severe cutaneous warts.
| Published in | American Journal of Internal Medicine (Volume 7, Issue 5) |
| DOI | 10.11648/j.sr.20190705.11 |
| Page(s) | 60-63 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Kidney Transplantation, Human Papilloma Virus, Ano-Genital Neoplasms
| [1] | Veroux M, Corona D, Scalia G, Garozzo V, Gagliano M, Giuffrida G, et al. Surveillance of human papilloma virus infection and cervical cancer in kidney transplant recipients: preliminary data. Transplant Proc. mai 2009; 41 (4): 1191-4. |
| [2] | Arze S, Arze L, Abecia C. Post-transplantation Infections in Bolivia. Transplant Proc. mars 2016; 48 (2): 646-53. |
| [3] | Alotaibi L, Provost N, Gagnon S, Franco EL, Coutlée F. Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion. J Clin Virol Off Publ Pan Am Soc Clin Virol. juin 2006; 36 (2): 133-40. |
| [4] | Skov Dalgaard L, Fassel U, Østergaard LJ, Jespersen B, SchmeltzSøgaard O, Jensen-Fangel S. Risk of human papillomavirus-related cancers among kidney transplant recipients and patients receiving chronic dialysis--an observational cohort study. BMC Nephrol. 8 juill 2013; 14: 137. |
| [5] | Shahidi S, Moeinzadeh F, Mohammadi M, Gholamrezaei A. Sirolimus-based immunosuppression for treatment of cutaneous warts in kidney transplant recipients. Iran J Kidney Dis. sept 2011; 5 (5): 351-3. |
| [6] | Bonatti H, Aigner F, De Clercq E, Boesmueller C, Widschwendner A, Larcher C, et al. Local administration of cidofovir for human papilloma virus associated skin lesions in transplant recipients. Transpl Int Off J Eur Soc Organ Transplant. mars 2007; 20 (3): 238-46. |
| [7] | Dharancy S, Catteau B, Mortier L, Boleslawski E, Declerck N, Canva V, et al. Conversion to sirolimus: a useful strategy for recalcitrant cutaneous viral warts in liver transplant recipient. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. déc 2006; 12 (12): 1883-7. |
| [8] | Chin-Hong PV, Kwak EJ, AST Infectious Diseases Community of Practice. Human papillomavirus in solid organ transplantation. Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. mars 2013; 13 Suppl 4: 189-200. |
APA Style
Kmar Mnif, Soumaya Yaich, Fatma Fendri, Abdelrahmen Masmoudi, Khaled Charfeddine, et al. (2019). Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient. American Journal of Internal Medicine, 7(5), 60-63. https://doi.org/10.11648/j.sr.20190705.11
ACS Style
Kmar Mnif; Soumaya Yaich; Fatma Fendri; Abdelrahmen Masmoudi; Khaled Charfeddine, et al. Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient. Am. J. Intern. Med. 2019, 7(5), 60-63. doi: 10.11648/j.sr.20190705.11
AMA Style
Kmar Mnif, Soumaya Yaich, Fatma Fendri, Abdelrahmen Masmoudi, Khaled Charfeddine, et al. Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient. Am J Intern Med. 2019;7(5):60-63. doi: 10.11648/j.sr.20190705.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.sr.20190705.11,
author = {Kmar Mnif and Soumaya Yaich and Fatma Fendri and Abdelrahmen Masmoudi and Khaled Charfeddine and Khawla Kammoun and Jamil Hachicha and Mohamed Ben Hmida},
title = {Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient},
journal = {American Journal of Internal Medicine},
volume = {7},
number = {5},
pages = {60-63},
doi = {10.11648/j.sr.20190705.11},
url = {https://doi.org/10.11648/j.sr.20190705.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sr.20190705.11},
abstract = {Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections worldwide and causes anal cancer. The incidence of HPV infections in renal transplant recipients is 17% to 45%. Using immunosuppression treatment has been associated with significantly lower risks of de novo malignancies and viral infections after kidney transplantation. We reported the results of switching Tacrolimus to Sirolimus in a kidney transplant recipient who suffered from severe cutaneous warts.},
year = {2019}
}
TY - JOUR T1 - Human Papilloma Virus Infection and Anal Cancer in Kidney Transplant Recipient AU - Kmar Mnif AU - Soumaya Yaich AU - Fatma Fendri AU - Abdelrahmen Masmoudi AU - Khaled Charfeddine AU - Khawla Kammoun AU - Jamil Hachicha AU - Mohamed Ben Hmida Y1 - 2019/10/16 PY - 2019 N1 - https://doi.org/10.11648/j.sr.20190705.11 DO - 10.11648/j.sr.20190705.11 T2 - American Journal of Internal Medicine JF - American Journal of Internal Medicine JO - American Journal of Internal Medicine SP - 60 EP - 63 PB - Science Publishing Group SN - 2330-4324 UR - https://doi.org/10.11648/j.sr.20190705.11 AB - Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections worldwide and causes anal cancer. The incidence of HPV infections in renal transplant recipients is 17% to 45%. Using immunosuppression treatment has been associated with significantly lower risks of de novo malignancies and viral infections after kidney transplantation. We reported the results of switching Tacrolimus to Sirolimus in a kidney transplant recipient who suffered from severe cutaneous warts. VL - 7 IS - 5 ER -
Information
Email: